Succeeding with world-class medicine

M1 Kliniken AG

Medical Care For a Better Life – with this vision M1 Kliniken AG, one of the fastest growing healthcare services providers in Germany, has developed an innovative concept, which offers affordable access to beauty treatments at highest qualitative standards.

M1 stock

ISIN: DE000A0STSQ8 | WKN: A0STSQ | Ticker symbol: M12

Title name: Bearer Share
Number of shares: 19.643.403
Stock exchange: Frankfurt, Stuttgart, Berlin, Düsseldorf, München, Hannover, Xetra, Hamburg, Tradegate Exchange
Market segment: Open Market
Designated Sponsoring: mwb fairtrade
Inital trading day: 14.09.2015

More information

| Investor News

The Supervisory Board of M1 Kliniken AG has appointed Ms. Katharina Zimmnau to the Executive Board of M1 Kliniken AG with effect from 10. December 2025.

| Investor News

  • Group revenue: +6.7% to EUR 274.3 million (YTD Q3 2024: EUR 257.2 million)
  • EBITDA: +9% to EUR 28.2 million (YTD Q3 2024: EUR 25.9 million)
  • EBIT: +11% to EUR 24.5 million (YTD Q3 2024: EUR 22.1 million)
  • EBIT margin: 8.9% (YTD Q3 2024: 8.6%)
  • EBT: +10% to EUR 24.4 million (YTD Q3 2024: EUR 22.2 million)
  • Earnings per share: EUR 0.86 (YTD Q3 2024: EUR 0.77)

| Investor News

  • Group revenue: +9.4% to EUR 183.5 million (H1 2024: EUR 167.7 million)
  • EBITDA: +21% to EUR 20.5 million (H1 2024: EUR 17.0 million)
  • EBIT: +24% to EUR 18.0 million (H1 2024: EUR 14.5 million)
  • EBIT margin: 9.8% (H1 2024: 8.6%)
  • EBT: +12% to EUR 16.9 million (H1 2024: EUR 15.0 million)
  • Earnings per share: EUR 0.63 (H1 2024: EUR 0.53)

Contact

M1 Kliniken AG

Grünauer Straße 5
12557 Berlin
Germany

T. +49 (0) 30 347 47 44 14

Contact us